Why the study?
Does antiplatelet therapy reduce stroke recurrence in patients with noncardioembolic stroke?
Population
Patients with noncardioembolic stroke
Design
Review
Authors
Loading...
May increase bleeding risk with early dual therapy; leaves open optimal antiplatelet regimen in noncardioembolic stroke.
Does antiplatelet therapy reduce stroke recurrence in patients with noncardioembolic stroke?
This review summarizes evidence that single antiplatelet therapy or specific combinations are effective for noncardioembolic stroke prevention, while aspirin plus clopidogrel increases bleeding risk.
Sandset et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: